Latest filing published 02 Aug 2006 for Altus Pharmaceuticals Inc., €9.1M.
Insider track record
No signal scores available.
Vertex Pharmaceuticals Inc / MA: trading record in brief
Vertex Pharmaceuticals Inc / MA discloses dealings in Altus Pharmaceuticals Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 31 January 2006 to 31 July 2006.
Every open-market trade on record is a sale: 1 sale worth €9.1M.
The latest filing, published on 2 August 2006, reports an open-market sale of €9.1M in Altus Pharmaceuticals Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Vertex Pharmaceuticals Inc / MA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 817,749 shares@ US$14.28Common StockSEC:0000875320-06-000072:0
- 381,596 shares@ US$5.73Common StockSEC:0000875320-06-000007:0
2 of 2 declarations